Experience

Davis Polk advised InnoCare Pharma Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…

Davis Polk is advising the financial adviser to Microchip Technology Incorporated in connection with Microchip’s privately negotiated exchanges of $615 million aggregate principal amount of…

Davis Polk advised Banco Votorantim S.A. in connection with a “Green Bond” offering of $50 million aggregate principal amount of 3.350% global medium-term notes due 2024, pursuant to…

Davis Polk advised Williams Companies in connection with the adoption by its Board of a limited duration shareholder rights plan. Under the rights plan, the rights would become exercisable…

Davis Polk is advising Li & Fung Limited on its HK$7.22 billion ($926 million) proposed privatization by Golden Lincoln Holdings I Limited as the offeror by way of a scheme of…

We advised affiliates of RXR Realty on the acquisition of properties

Davis Polk advised Tianfeng Securities Co., Ltd. in connection with its $100 million notes offering. The notes will be consolidated and form a single series with the $200 million notes…

Davis Polk advised Exxon Mobil Corporation on the SEC-registered offering of $1.5 billion principal amount of 2.992% notes due 2025, $1 billion principal amount of 3.294% notes due 2027, $2…

Davis Polk advised the dealers in connection with the establishment of $2 billion medium-term note program by China Cinda (2020) I Management Limited which is a wholly owned subsidiary of…

Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by Textron Inc. of $650 million aggregate principal amount of its 3.0%…